publication venue for
- MRI, Efficacy, and Safety of Tolebrutinib in Highly Active Disease: 2-Year Data from Phase 2b Long-term Safety Study 2023
- Serum neurofilament light chain levels during natalizumab treatment with every-4-week and every-6-week dosing in NOVA 2023
- Physical activity and brain health in patients with atrial fibrillation 2023
- A systematic review of non-interventional studies reporting on humanistic and economic burden of cognitive decline in multiple sclerosis patients regardless of study design 2018
- A pilot study to examine the single dose pharmacokinetic properties of two formulations of Apomorphine Sublingual Film (APL-130277) 15 mg in health volunteers 2017
- Oral sublingual apomorphine film (APL-130277) produces no buccal mucosal irritation: results of a toxicological study 2016
- Treatment of OFF episodes in Parkinson's disease: an evaluation of patient and caregiver insights 2016
- Treatment of OFF episodes in Parkinson's disease: an evaluation of physician practices 2016
- Efficacy of sublingual apomorphine (APL-130277) for the treatment of "Off" episodes in patients with Parkinson's disease 2015
- Safety of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease 2015
- 15-30 Hz corticomuscular and intermuscular coherence is absent in patients with primary lateral sclerosis 2008
- Over-the-counter medication in migraine: a questionnaire-based analysis in migraineurs in Spain 2008
- The effect of levetiracetam on cerebellar intention tremor in patients with multiple sclerosis 2008
- The importance of initial drug choice when treating migraine: a questionnaire-based analysis of migraineurs in Spain 2008
- Patient strategies for the management of migraine: Interim results from an online market research study (MAZE study phase IV) 2004
- Blood pressure variability in acute stroke: Risk factors and association with functional outcomes at 1 month. 31:e16314. 2024
-
Pre‐morbid sleep disturbance and its association with stroke severity: results from the international
INTERSTROKE study. 31:e16193. 2024 - Does prior use of antiplatelet therapy modify the effect of dual antiplatelet therapy in transient ischaemic attack/minor ischaemic stroke: A systematic review and meta‐analysis. 29:2864-2868. 2022
- Brain iron deposition and movement disorders in hereditary haemochromatosis without liver failure: A cross‐sectional study. 29:1417-1426. 2022
- Endovascular treatment for basilar artery occlusion: A systematic review and meta‐analysis. 28:2106-2110. 2021
- Blood pressure changes during alemtuzumab infusion for multiple sclerosis patients. 28:1396-1400. 2021
- Response to letter: non‐vitamin‐K oral anticoagulants may not significantly reduce the risk of fatal or disabling stroke compared with warfarin. 27:e56. 2020
- EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. 27:1117-1136. 2020
- Statin treatment and accrual of covert cerebral ischaemia on neuroimaging: a systematic review and meta‐analysis of randomized trials. 27:1023-1027. 2020
- Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial. 27:841-848. 2020
- Serious infections in patients with myasthenia gravis: population‐based cohort study. 27:702-708. 2020
- Effect of non‐vitamin‐K oral anticoagulants on stroke severity compared to warfarin: a meta‐analysis of randomized controlled trials. 27:413-418. 2020
- In‐hospital myocardial infarction following acute ischaemic stroke: an observational study. 16:1035-1040. 2009
- Acute disseminated encephalomyelitis: clinical features and HLA‐DR linkage. 11:354-354. 2004